First-in-human ex-vivo validation of carbonic anhydrase IX-PET for high-risk renal cancer (CAT-VHL - PNRR-POC-2023-12377493).

Larcher A, Gelardi F, Antunovic L, Savi A, Olivieri M, Rainone P, Sollini M, Moresco RM, Re C, Cei F, Belladelli F, Musso G, Salerno L, De Cobelli F, Tenace N, Ponzoni M, Cigliola A, Verze P, Bertini R, Briganti A, Montorsi F, Capitanio U, Salonia A, Chiti A

Open source

DOI: 10.7150/thno.122256
Published: 2026
Container: Theranostics
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.7150/thno.122256,
  title = {First-in-human ex-vivo validation of carbonic anhydrase IX-PET for high-risk renal cancer (CAT-VHL - PNRR-POC-2023-12377493).},
  author = {Larcher A and Gelardi F and Antunovic L and Savi A and Olivieri M and Rainone P and Sollini M and Moresco RM and Re C and Cei F and Belladelli F and Musso G and Salerno L and De Cobelli F and Tenace N and Ponzoni M and Cigliola A and Verze P and Bertini R and Briganti A and Montorsi F and Capitanio U and Salonia A and Chiti A},
  year = {2026},
  journal = {Theranostics},
  doi = {10.7150/thno.122256},
  url = {https://doi.org/10.7150/thno.122256}
}

RIS

TY  - JOUR
TI  - First-in-human ex-vivo validation of carbonic anhydrase IX-PET for high-risk renal cancer (CAT-VHL - PNRR-POC-2023-12377493).
AU  - Larcher A
AU  - Gelardi F
AU  - Antunovic L
AU  - Savi A
AU  - Olivieri M
AU  - Rainone P
AU  - Sollini M
AU  - Moresco RM
AU  - Re C
AU  - Cei F
AU  - Belladelli F
AU  - Musso G
AU  - Salerno L
AU  - De Cobelli F
AU  - Tenace N
AU  - Ponzoni M
AU  - Cigliola A
AU  - Verze P
AU  - Bertini R
AU  - Briganti A
AU  - Montorsi F
AU  - Capitanio U
AU  - Salonia A
AU  - Chiti A
PY  - 2026
JO  - Theranostics
DO  - 10.7150/thno.122256
UR  - https://doi.org/10.7150/thno.122256
ER  -

APA

A, L., F, G., L, A., A, S., M, O., P, R., M, S., RM, M., C, R., F, C., F, B., G, M., L, S., F, D. C., N, T., M, P., A, C., P, V., R, B., A, B., F, M., U, C., A, S., & A, C. (2026). First-in-human ex-vivo validation of carbonic anhydrase IX-PET for high-risk renal cancer (CAT-VHL - PNRR-POC-2023-12377493).. Theranostics. https://doi.org/10.7150/thno.122256

Source records

pubmed · retrieved 2026-09-26T21:39:38.207Z